BlackRock’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39K | Sell |
2,037
-72,663
| -97% | -$49.4K | ﹤0.01% | 5267 |
|
|
2025
Q1 | $54.1K | Sell |
74,700
-1,386
| -2% | -$1K | ﹤0.01% | 4859 |
|
|
2024
Q4 | $72.7K | Buy |
76,086
+462
| +0.6% | +$441 | ﹤0.01% | 4799 |
|
|
2024
Q3 | $59.6K | Buy |
75,624
+9,206
| +14% | +$7.25K | ﹤0.01% | 4723 |
|
|
2024
Q2 | $62.9K | Buy |
66,418
+21,063
| +46% | +$20K | ﹤0.01% | 4760 |
|
|
2024
Q1 | $49K | Sell |
45,355
-1,507
| -3% | -$1.63K | ﹤0.01% | 4812 |
|
|
2023
Q4 | $25.8K | Sell |
46,862
-522
| -1% | -$287 | ﹤0.01% | 4979 |
|
|
2023
Q3 | $100K | Sell |
47,384
-1,827
| -4% | -$3.86K | ﹤0.01% | 4783 |
|
|
2023
Q2 | $129K | Sell |
49,211
-1,794
| -4% | -$4.7K | ﹤0.01% | 4756 |
|
|
2023
Q1 | $162K | Buy |
51,005
+1,566
| +3% | +$4.96K | ﹤0.01% | 4748 |
|
|
2022
Q4 | $133K | Buy |
49,439
+3,081
| +7% | +$8.29K | ﹤0.01% | 4874 |
|
|
2022
Q3 | $135K | Sell |
46,358
-1,305
| -3% | -$3.8K | ﹤0.01% | 4995 |
|
|
2022
Q2 | $139K | Sell |
47,663
-252,093
| -84% | -$735K | ﹤0.01% | 5049 |
|
|
2022
Q1 | $2.12M | Sell |
299,756
-24,338
| -8% | -$172K | ﹤0.01% | 4279 |
|
|
2021
Q4 | $5.18M | Buy |
+324,094
| New | +$5.18M | ﹤0.01% | 3920 |
|